Characteristics of final TB patient sample at TB treatment start, ART exposure and TB treatment duration.

*2 months of rifampicin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E), followed by 4 months of rifampicin (R) and isoniazid (H). Patients not on this recommended regimen were either receiving different treatment due to side effects, or were receiving streptomycin instead of ethambutol with a diagnosis of extrapulmonary meningitis.IQR = interquartile range. ART = antiretroviral therapy. BMI = body mass index. CPT = cotrimoxazole preventive therapy. TB = tuberculosis.治疗方案为：先接受2个月的利福平（rifampicin, R）、异烟肼（isoniazid, H）、吡嗪酰胺（pyrazinamide, Z）与乙胺丁醇（ethambutol, E）联合治疗，随后接受4个月的利福平（rifampicin, R）与异烟肼（isoniazid, H）联合治疗。未遵循该推荐治疗方案的患者，要么因出现不良反应而调整了治疗方案，要么因被诊断为肺外脑膜炎（extrapulmonary meningitis），采用链霉素（streptomycin）替代乙胺丁醇进行治疗。本说明中各缩写的含义如下：IQR为四分位距（interquartile range）；ART为抗反转录病毒治疗（antiretroviral therapy）；BMI为体重指数（body mass index）；CPT为复方新诺明预防治疗（cotrimoxazole preventive therapy）；TB为结核病（tuberculosis）。